← Browse by Condition
Medical Condition

locally advanced her2 positive breast carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05319873 Phase 1, Phase 2
Recruiting

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Enrollment
18 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C...
View Trial →